Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
House Dust Mite Allergy Market Size, Value And Growth Trajectory Through 2030
The house dust mite allergy market has experienced significant growth in recent years. It is projected to increase from $2.37 billion in 2025 to $2.7 billion in 2026, showing a compound annual growth rate (CAGR) of 14.3%. This historical expansion can be attributed to the rising incidence of allergic conditions, heightened awareness regarding respiratory allergies, an increase in the accessibility of diagnostic testing, the growing use of antihistamine medications, and refinements in allergy treatment protocols.
The house dust mite allergy market is projected to experience substantial expansion in the coming years. This market is set to reach a valuation of $4.62 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.3%. The anticipated growth during this period stems from several factors, including the increasing embrace of personalized immunotherapy, a heightened emphasis on preventive allergy care, the broadening availability of home-based allergy management, an escalating need for sustained symptom control, and progress in biologic allergy treatments. Key developments anticipated in the forecast horizon encompass a rise in the adoption of immunotherapy-based solutions, a growing prevalence of sublingual allergy tablets, an increased requirement for enduring allergy management strategies, the wider acceptance of early diagnostic testing, and a reinforced commitment to individualized allergy treatment approaches.
Get A Free Sample Report With In-Depth Market Insights:
House Dust Mite Allergy Market Growth Factors: What’s Supporting Expansion?
The increasing incidence of asthma conditions is anticipated to fuel the expansion of the house dust mite allergy market in the foreseeable future. Asthma is defined as a persistent inflammatory disorder of the airways, marked by repeated occurrences of difficulty breathing, whistling sounds during breathing, tightness in the chest, and coughing. The rise in asthma cases is attributed to increasing environmental contamination, which leads to greater inflammation in the airways and heightened susceptibility to allergens. Consequently, the house dust mite allergy market is experiencing heightened demand, as the swift growth of asthma conditions prompts businesses to implement strategies for minimizing allergen exposure and improving respiratory well-being. For example, data from June 2025 by the American Lung Association, a US-based nonprofit health entity, indicated significant variability in adult asthma prevalence across US jurisdictions, varying from 7.1% in Mississippi to 14.1% in Puerto Rico as of 2023. Hence, the widespread occurrence of asthma diseases is a key factor boosting the demand within the house dust mite allergy market.
House Dust Mite Allergy Market Segment Landscape And Growth Outlook
The house dust mite allergy market covered in this report is segmented –
1) By Product Type: Tablets, Nasal Drops, Injectable
2) By Diagnosis: Skin Prick Test (SPT), Specific Immunoglobulin E (IgE) Blood Test, Other Diagnosis
3) By Dosage Forms: Solid, Liquid
4) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Tablets: Sublingual Tablets, Oral Tablets
2) By Nasal Drops: Antihistamine Nasal Drops, Corticosteroid Nasal Drops
3) By Injectable: Allergen Immunotherapy Injections, Corticosteroid Injections
House Dust Mite Allergy Market Industry Trends: What’s Reshaping Demand?
Leading companies within the house dust mite allergy market are concentrating on creating novel therapies, specifically sublingual tablets for house dust mite allergies, to combat the rising incidence of these allergic conditions. A sublingual tablet for house dust mite allergies functions as a form of immunotherapy, requiring the tablet to be positioned under the tongue where it dissolves, releasing controlled quantities of the allergen that causes the allergic response. As an example, in January 2023, the Danish pharmaceutical firm ALK-Abelló A/S secured FDA approval for ODACTRA, a sublingual tablet aimed at treating house dust mite allergies in adolescents between 12 to 17 years old, extending its prior approval for adult use. This particular approval addresses a considerable unmet need, given that close to 50% of individuals experiencing allergies exhibit sensitivity to house dust mites. Clinical studies showed ODACTRA’s effectiveness in lessening allergy symptoms, presenting a safety profile comparable to that seen in adult patients. Although this treatment is typically well-received, patients are cautioned to keep auto-injectable epinephrine readily available because of the possibility of severe allergic responses.
House Dust Mite Allergy Market Competitive Overview And Top Companies
Major companies operating in the house dust mite allergy market are Allergy Therapeutics Plc, Bayer AG, Catalent Inc., GSK Plc, Merz Pharma GmbH & Co KGaA, Sanofi S A, Shionogi & Co. Ltd., Stallergenes Greer International AG, Merck & Co. Inc., Torii Pharmaceutical Co. Ltd., Ergomed PLC, DMS Group, HAL Allergy Group, Trio Lifescience Private Limited, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Johnson and Johnson Inc., Circassia Pharmaceuticals Plc, Biomay Ag, GlaxoSmithKline
View The Full House Dust Mite Allergy Market Report:
House Dust Mite Allergy Market Leading Geography: Which Region Contributes The Most Revenue?
North America was the largest region in the house dust mite allergy market in 2025. Asia-pacific is expected to be the fastest-growing region in the house dust mite allergy market report during the forecast period. The regions covered in the house dust mite allergy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
